AU2001234189A1 - Vitamin d derivatives having substituents at the 2alpha-position - Google Patents

Vitamin d derivatives having substituents at the 2alpha-position

Info

Publication number
AU2001234189A1
AU2001234189A1 AU2001234189A AU3418901A AU2001234189A1 AU 2001234189 A1 AU2001234189 A1 AU 2001234189A1 AU 2001234189 A AU2001234189 A AU 2001234189A AU 3418901 A AU3418901 A AU 3418901A AU 2001234189 A1 AU2001234189 A1 AU 2001234189A1
Authority
AU
Australia
Prior art keywords
2alpha
vitamin
substituents
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234189A
Inventor
Toshie Fujishima
Atsushi Kittaka
Yoshitomo Suhara
Hiroaki Takayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU2001234189A1 publication Critical patent/AU2001234189A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2001234189A 2000-02-28 2001-02-27 Vitamin d derivatives having substituents at the 2alpha-position Abandoned AU2001234189A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000050915 2000-02-28
JP2000-50915 2000-02-28
PCT/JP2001/001451 WO2001062723A1 (en) 2000-02-28 2001-02-27 VITAMIN D DERIVATIVES HAVING SUBSTITUENTS AT THE 2α-POSITION

Publications (1)

Publication Number Publication Date
AU2001234189A1 true AU2001234189A1 (en) 2001-09-03

Family

ID=18572644

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234189A Abandoned AU2001234189A1 (en) 2000-02-28 2001-02-27 Vitamin d derivatives having substituents at the 2alpha-position

Country Status (6)

Country Link
US (1) US20030022872A1 (en)
EP (1) EP1260502A1 (en)
KR (1) KR20020092955A (en)
CN (1) CN1398254A (en)
AU (1) AU2001234189A1 (en)
WO (1) WO2001062723A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011241170A (en) * 2010-05-18 2011-12-01 Mercian Corp Vitamin d derivative and method for producing the same
SG189427A1 (en) * 2010-10-25 2013-05-31 Teijin Pharma Ltd 23-yne-vitamin d3 derivative
WO2013162047A1 (en) * 2012-04-24 2013-10-31 帝人ファーマ株式会社 Therapeutic agent for secondary hyperparathyroidism
WO2020229470A1 (en) * 2019-05-13 2020-11-19 Faes Farma, S.A. Process and intermediates for the preparation of eldecalcitol
CN114685553B (en) * 2020-12-29 2024-01-30 南京圣鼎医药科技有限公司 Preparation method of idecalcitol intermediate and intermediate thereof
CN115057804B (en) * 2022-05-27 2024-03-29 南京海融制药有限公司 Calcitriol purification method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0780773B2 (en) * 1986-06-05 1995-08-30 中外製薬株式会社 New Vitamin D (3) A drug containing a derivative as an active ingredient
PT806413E (en) * 1995-01-23 2002-03-28 Chugai Pharmaceutical Co Ltd VITAMIN D3 DERIVATIVES SUBSTITUTED IN POSITION 2

Also Published As

Publication number Publication date
KR20020092955A (en) 2002-12-12
EP1260502A1 (en) 2002-11-27
WO2001062723A1 (en) 2001-08-30
CN1398254A (en) 2003-02-19
US20030022872A1 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2002349676A1 (en) 4-oxoquinoline derivatives
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2001264280A1 (en) Vitamin D derivatives
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2001248777A1 (en) Vitamin d derivatives
AU2002352357A1 (en) Trioxane derivatives
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2001274265A1 (en) Sulphonamide derivatives
AU2002220578A1 (en) O-substituted 6-methyl-tramadol derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU3167699A (en) Vitamin d derivatives substituted at the 2beta-position
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2001241512A1 (en) Sulfonamide derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU2001234189A1 (en) Vitamin d derivatives having substituents at the 2alpha-position
AU2002212263A1 (en) Substituted 5-amino-1-pentene-3-ol derivatives